Mounjaro® – A Breakthrough in Diabetes & Weight Loss Care
Key Benefits
- Improves blood sugar control in adults with type 2 diabetes
- Clinically proven to support substantial weight loss
- Convenient once-weekly injection
- Helps reduce appetite and overeating
- May lower the risk of heart-related complications
Mounjaro may be ideal if you:
- Have type 2 diabetes and are not meeting your A1C goals with current treatments
- Struggle with excess weight or obesity
- Are looking for a comprehensive treatment to address blood sugar and weight together
- Are working under the guidance of a healthcare provider for long-term metabolic health
Note: Mounjaro is not approved for type 1 diabetes or as a standalone weight loss drug, but many providers use it off-label for weight management.
How Mounjaro Works
Mounjaro is the first and only dual GIP and GLP-1 receptor agonist, meaning it mimics two natural incretin hormones (GIP and GLP-1) that help regulate blood sugar and appetite.
It works by:
- Increasing insulin production when blood sugar is high
- Reducing the liver’s glucose output
- Slowing stomach emptying to help you feel full longer
- Decreasing hunger and food intake
Description
What is Mounjaro?
Mounjaro® is a cutting-edge, once-weekly injectable prescription medication containing tirzepatide, designed for adults with type 2 diabetes. Approved by the FDA, Mounjaro not only helps manage blood sugar levels but has shown significant weight loss results, making it a dual-purpose therapy for both glycemic control and obesity management.
